EOLS Q4 2019 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena

EOLSEvolus, Inc.

$338M

Q4 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$19M

Gross Profit

$14M73.8% margin

Operating Income

-$16M-84.1% margin

Net Income

-$15M-74.6% margin

EPS (Diluted)

$-0.47

QoQ Revenue Growth

+47.7%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$17M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$240M

Total Liabilities

$161M

Stockholders' Equity

$79M

Cash & Equivalents

$110M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$0	—
Gross Profit	$14M	$0	—
Operating Income	-$16M	-$13M	-30.8%
Net Income	-$15M	-$12M	-16.6%